Daniel Sterman, MD, evaluates patients at NYU Langone Pulmonary and Critical Care Associates and Perlmutter Cancer Center, diagnosing and treating people who have lung cancer, malignant pleural mesothelioma, and pleural effusion, which is a buildup of fluid between those membranes. He diagnoses and manages cancers and benign disorders affecting the large airways of the lungs: the trachea and bronchi. Dr. Sterman also performs staging procedures to determine the degree of advancement of a person’s condition.
In addition to offering a variety of chest services across the hospital, Dr. Sterman participates in novel research and clinical trials. He has spent the last 18 years studying ways to use gene therapy and immunotherapy to control tumors of the chest, treat people with both lung cancer and malignant pleural mesothelioma, and improve and prolong the quality of patients’ lives.
